Medicalsystem Biotechnology Co., Ltd. (300439.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.78B
Enterprise Value3.2B
P/E Ratio52.16
PEG Ratio-1.07
Price/Sales Ratio2.17
Price/Book Ratio1.2
Enterprise/Revenue1.87
Enterprise/EBITDA16.34

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.04
Operating Margin0.01
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.02

Income Statement

Revenue1.53B
Revenue/Share4.15
Gross Profit496.38M
EBITDA230.28M
Net Income63.2M
Diluted EPS0.16

Balance Sheet

Total Cash1.04B
Total Cash/Share2.65
Total Debt94.58M
Total Debt/Equity0.03
Current Ratio3.1
Book Value Per Share7.62

Price History

52-Week Change-15.22
52-Week High11.11
52-Week Low7.83
Moving Average 50 Days8.97
Moving Average 200 Days9.59

Statistics

Average Volume3.69M
Shares Outstanding384.32M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.03
Trailing Annual Dividend Yield0.36
Payout Ratio1.2
Last Split Factor3:1
Last Split DateSeptember 17, 2015
AD